Bausch Health Companies Inc
BHC5.714USD
+0.004+0.07%
Horário de mercado （ET）Cotações atrasadas em 15 min
2.11BValor de mercado
PerdaP/L TTM
Mais detalhes de Bausch Health Companies Inc Empresa
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products, and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.
Informações da empresa
Código da empresaBHC
Nome da EmpresaBausch Health Companies Inc
Data de listagemSep 20, 1994
CEOMr. Thomas J. Appio
Número de funcionários20700
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 20
Endereço2150 St. Elzear Blvd. West
CidadeLAVAL
Bolsa de valoresThe Toronto Stock Exchange
PaísCanada
Código postalH7L 4A8
Telefone18003611448
Sitehttps://www.bauschhealth.com/
Código da empresaBHC
Data de listagemSep 20, 1994
CEOMr. Thomas J. Appio
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
627.22K
-24.81%
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
264.39K
+0.39%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
254.72K
+27.12%
Mr. Steven D. Miller
Mr. Steven D. Miller
Independent Director
Independent Director
239.22K
+29.40%
Mr. Brett M. Icahn
Mr. Brett M. Icahn
Independent Director
Independent Director
225.40K
+1.82%
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
30.15K
--
Mr. Michael Goettler
Mr. Michael Goettler
Director
Director
30.15K
--
Ms. Aimee J. Lenar
Ms. Aimee J. Lenar
Executive Vice President, US Pharma
Executive Vice President, US Pharma
8.11K
--
Dr. Richard C. Mulligan, Ph.D.
Dr. Richard C. Mulligan, Ph.D.
Independent Director
Independent Director
--
--
Mr. John A. Paulson
Mr. John A. Paulson
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
627.22K
-24.81%
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
264.39K
+0.39%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
254.72K
+27.12%
Mr. Steven D. Miller
Mr. Steven D. Miller
Independent Director
Independent Director
239.22K
+29.40%
Mr. Brett M. Icahn
Mr. Brett M. Icahn
Independent Director
Independent Director
225.40K
+1.82%
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
30.15K
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Pharmaceutical Products
4.40B
45.67%
Device Products
2.24B
23.27%
OTC
1.90B
19.77%
Branded and Other Generic Products
979.00M
10.17%
Other Product Lines
107.00M
1.11%
Por RegiãoUSD
Nome
Receita
Proporção
United States and Puerto Rico
5.77B
59.92%
Other Foreign Countries
1.08B
11.25%
China (Country)
496.00M
5.15%
Canada
402.00M
4.18%
Poland
350.00M
3.64%
Other
1.53B
15.86%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Pharmaceutical Products
4.40B
45.67%
Device Products
2.24B
23.27%
OTC
1.90B
19.77%
Branded and Other Generic Products
979.00M
10.17%
Other Product Lines
107.00M
1.11%
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Meruelo (Alex)
9.94%
Icahn Associates Corporation
9.39%
Paulson & Co. Inc.
8.87%
GoldenTree Asset Management, LP
8.18%
Nomura Securities Co., Ltd.
6.33%
Other
57.29%
Investidores
Investidores
Proporção
Meruelo (Alex)
9.94%
Icahn Associates Corporation
9.39%
Paulson & Co. Inc.
8.87%
GoldenTree Asset Management, LP
8.18%
Nomura Securities Co., Ltd.
6.33%
Other
57.29%
Tipos de investidores
Investidores
Proporção
Hedge Fund
16.44%
Investment Advisor/Hedge Fund
16.30%
Individual Investor
11.04%
Family Office
8.87%
Research Firm
8.65%
Investment Advisor
8.64%
Bank and Trust
4.41%
Pension Fund
4.26%
Private Equity
1.42%
Other
19.98%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
514
263.21M
71.22%
-46.16M
2025Q1
547
263.71M
71.37%
-49.89M
2024Q4
568
275.73M
74.96%
-32.06M
2024Q3
627
279.89M
77.25%
-44.78M
2024Q2
703
283.62M
78.54%
-59.67M
2024Q1
764
278.87M
76.11%
-93.72M
2023Q4
801
283.62M
78.55%
-85.16M
2023Q3
821
301.23M
82.72%
-52.06M
2023Q2
836
283.61M
80.53%
-76.52M
2023Q1
862
290.05M
79.80%
-77.57M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Meruelo (Alex)
36.76M
9.95%
+148.73K
+0.41%
Mar 31, 2025
Icahn Associates Corporation
34.72M
9.4%
--
--
May 20, 2025
Paulson & Co. Inc.
32.79M
8.87%
+6.35M
+24.03%
Jun 13, 2025
GoldenTree Asset Management, LP
30.25M
8.19%
+2.71M
+9.84%
Mar 31, 2025
Nomura Securities Co., Ltd.
23.39M
6.33%
+12.05M
+106.21%
Mar 31, 2025
Healthcare Of Ontario Pension Plan
13.00M
3.52%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
11.68M
3.16%
+61.62K
+0.53%
Mar 31, 2025
National Bank of Canada
7.51M
2.03%
-7.91M
-51.29%
Mar 31, 2025
Maple Rock Capital Partners, Inc.
6.80M
1.84%
+1.50M
+28.25%
Mar 31, 2025
Macquarie Investment Management Global Ltd.
6.60M
1.79%
--
--
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
Gotham 1000 Value ETF
0.18%
VanEck Pharmaceutical ETF
0.14%
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
0.12%
JPMorgan International Value ETF
0.09%
Schwab International Small-Cap Equity ETF
0.08%
iShares Intl Small Cap Equity Factor ETF
0.06%
DFA Dimensional International Small Cap ETF
0.05%
Schwab Fundamental International Equity ETF
0.04%
Invesco RAFI Developed Mkts ex-US ETF
0.03%
DFA Dimensional Intl Sustainability Core 1 ETF
0.01%
Ver Mais
Gotham 1000 Value ETF
Proporção0.18%
VanEck Pharmaceutical ETF
Proporção0.14%
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
Proporção0.12%
JPMorgan International Value ETF
Proporção0.09%
Schwab International Small-Cap Equity ETF
Proporção0.08%
iShares Intl Small Cap Equity Factor ETF
Proporção0.06%
DFA Dimensional International Small Cap ETF
Proporção0.05%
Schwab Fundamental International Equity ETF
Proporção0.04%
Invesco RAFI Developed Mkts ex-US ETF
Proporção0.03%
DFA Dimensional Intl Sustainability Core 1 ETF
Proporção0.01%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
